DMCRN-02-001: Assessing Pediatric Endpoints in DM1
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
Recruiting · NCT05224778 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DMCRN-02-001: Assessing Pediatric Endpoints in DM1 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Not stated | 2026-06-10 | NCT05224778 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Virginia Commonwealth University | 122 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro Clinico Nemo | Milan | Italy | 3 |
| University of California, Los Angeles | Los Angeles | United States | 142 |
| University of Kansas Medical Center | Fairway | United States | 18 |
| University of Rochester Medical Center | Rochester | United States | 162 |
| Virginia Commonwealth University | Richmond | United States | 156 |